Top Biotechnology & Medical Research stocks in Hong Kong
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
2269WuXi Biologics (Cayman) | HK$62.46bn | 17.31 | n/a |
9926Akeso | HK$43.25bn | 19.06 | n/a |
6990Sichuan Kelun-Biotech Biopharmaceutical Co | HK$41.43bn | n/a | n/a |
1548Genscript Biotech | HK$26.68bn | n/a | n/a |
2162Keymed Biosciences | HK$11.32bn | n/a | n/a |
2157Lepu Biopharma Co | HK$9.67bn | n/a | n/a |
2509Qyuns Therapeutics Co | HK$6.02bn | n/a | n/a |
6855Ascentage Pharma International | HK$5.83bn | n/a | n/a |
9966Alphamab Oncology | HK$5.05bn | n/a | n/a |
2315Biocytogen Pharmaceuticals Beijing Co | HK$3.89bn | n/a | n/a |
2171CARsgen Therapeutics Holdings | HK$3.55bn | n/a | n/a |
1541ImmuneOnco Biopharmaceuticals Shanghai | HK$3.33bn | n/a | n/a |
2511HighTide Therapeutics | HK$3.20bn | n/a | n/a |
2105Laekna | HK$2.57bn | n/a | n/a |
1521Frontage Holdings | HK$2.50bn | 26.68 | n/a |
2256Abbisko Cayman | HK$2.42bn | n/a | n/a |
6978Immunotech Biopharm | HK$1.74bn | n/a | n/a |
2181Mabpharm | HK$1.55bn | n/a | n/a |
2552Hua Medicine | HK$1.49bn | n/a | n/a |
1167Jacobio Pharmaceuticals Co | HK$1.47bn | n/a | n/a |